Chargement en cours...
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
Chronic myeloid leukemia was the first haematological neoplasia that benefited from a targeted therapy with imatinib nearly 15 years ago. Since then, several studies have investigated the role of genes, their variants (i.e., polymorphisms) and their encoded proteins in the pharmacokinetics and pharm...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613337/ https://ncbi.nlm.nih.gov/pubmed/26402671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms160922811 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|